The second edition of this popular textbook written for undergraduates, graduate students, and medical researchers, Genetics and Genomics in Medicine explains the science behind the uses of genetics and genomics in medicine today. This second edition has been thoroughly updated in line with the latest developments in the field.

The second edition of this popular textbook written for undergraduates, graduate students, and medical researchers, Genetics and Genomics in Medicine explains the science behind the uses of genetics and genomics in medicine today. This second edition has been thoroughly updated in line with the latest developments in the field.

Highly valued across the world by genetic counsellors, medical geneticists and other healthcare professionals, Harper's Practical Genetic Counselling has established itself over previous editions as the essential guide to counselling those at risk from inherited disorders.

Authored by 40 authorities in genetics and dysmorphology, this streamlined new edition offers an authoritative and richly illustrated guide to clinical presentation, associated anomalies, treatment, and prognosis.

Addresses the challenge of calculations in genetic counselling problem and demonstrates how risk can be estimated for inherited disorders using a basic knowledge of the laws of probability and their application to clinical problems. This text is aimed at genetic counsellors, geneticists, and those involved in providing medical genetic services.

Molecular Genetic Pathology, Second Edition presents up-to-date material containing fundamental information relevant to the clinical practice of molecular genetic pathology.

Provides contemporary insights into how the genetic revolution is influencing medical thinking and practice. The title includes advanced changes in personalized medicine, growth in omics and direct-to-consumer DNA testing, while focusing on advances in the Human Genome project and implications of the advances in clinical medicine.

The availability of powerful genome-wide association study technology, during the last five years, has shown that most of the "new" MS susceptibility loci are immune-response genes.